Switzerland's Cytos Biotechnology and Singapore's Agency for Science, Technology and Research (A*STAR) have jointly announced their first collaboration on a virus-like particle (VLP) vaccine. This partnership, which involves academic and clinical partners across Singapore, aims at research...